# clm_4C3C0E706B52

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 32,229,000,000 United States dollar  
valid_from: 2017-09-30  
valid_to: 2017-12-31  
published: 2017-10-26  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C6D997322E62  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 32,229,000,000 United States dollar", as of 2017-09-30 (until 2017-12-31). Claim clm_4C3C0E706B52, https://asof.is/claim/clm_4C3C0E706B52, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815417000027/0000318154-17-000027-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-10-26  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815417000027/0000318154-17-000027-index.htm (primary, SEC EDGAR 10-Q Q3 FY2017, published 2017-10-26)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 31,722,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_4C3C0E706B52](/claim/clm_4C3C0E706B52.md) | [clm_E6437073D865](/claim/clm_E6437073D865.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.